Evidence map›Paper›PMID 22241076›Full record

ReviewCurrent opinion in gastroenterology2012

Innate immunity in the small intestine.

Rebeca Santaolalla, Maria T Abreu

Abstract readReview
In one paragraph

Review in Current opinion in gastroenterology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Multifaceted intestinal defense following experimental blunt abdominal trauma.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Veterinary sciences · 2025
    Article
  7. Article
  8. Review
  9. Polysaccharide fromInternational journal of molecular sciences · 2024
    Article
  10. Novel Probiotic BacteriumMicroorganisms · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Eosinophils and Bacteria, the Beginning of a Story.International journal of molecular sciences · 2021
    Review
  17. Review
  18. Review
  19. Article
  20. Frontiers in immunology · 2021
    Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rebeca SantaolallaDivision of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
Maria T Abreu

Funding

Role of TLR4 in Colitis Associated NeoplasiaR01DK099076 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Maria Teresa Abreu · 2014 to 2026
$4.7M
Role of TLR4 in colitis-associated neoplasiaR01CA137869 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ABREU, MARIA TERESA · 2009 to 2013
$1.5M
NCI NIH HHS R01 CA137869NIDDK NIH HHS R01 DK099076
6 · The paper itself

Abstract

purpose of reviewThis article reviews the most recent publications on innate immunity in the small intestine. We will go over the innate immune receptors that act as sensors of microbial presence or cell injury, Paneth cells as the main epithelial cell type that secrete antimicrobial peptides, and mucosal production of immunoglobulin A (IgA). In addition, we will give an update on examples of imbalance of the innate immune response resulting in clinical disease with the most relevant example being Crohn's disease. RECENT

findingsToll-like receptors (TLRs) are involved in B-cell homing to the intestine, rejection of small intestinal allografts, and recruitment of mast cells. The TLR adaptor Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-β is necessary to activate innate immunity after Yersinia enterocolitica infection. Moreover, MyD88 is required to keep the intestinal microbiota under control and physically separated from the epithelium, and RegIIIγ is responsible for the bacterial segregation from the lining epithelial cells. In Crohn's disease, ATG16L1 T300A variant promotes a proinflammatory response; and miR-196 downregulates a protective immunity-related GTPase family M protein (IRGM) polymorphism leading to impaired clearance of adherent Escherichia coli in the intestine. SUMMARY: The intestine is continuously exposed to dietary and microbial antigens. The host has to maintain intestinal homeostasis to keep the commensal and pathogenic bacteria under control. Some of the mechanisms to do so are by expression of innate immune receptors, production of antimicrobial peptides, secretion of IgA, or autophagy of intracellular bacteria. Unfortunately, in some cases the innate immune response fails to protect the host and chronic inflammation, transplant rejection, or other disorders may occur.

Indexed as

Immunity, InnateAnimalsB-LymphocytesCell MovementCrohn DiseaseHomeostasisHumansImmunoglobulin AIntestine, SmallPaneth CellsSignal TransductionToll-Like ReceptorsImmunoglobulin AToll-Like Receptors

Identifiers

PMID22241076
PMCPMC3502878

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.